Transhepatic tract hemostasis using thermal-ablation after percutaneous portal vein access.
Détails
Télécharger: 35136636_BIB_974485F89B91.pdf (462.52 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_974485F89B91
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Transhepatic tract hemostasis using thermal-ablation after percutaneous portal vein access.
Périodique
BJR case reports
ISSN
2055-7159 (Electronic)
ISSN-L
2055-7159
Statut éditorial
Publié
Date de publication
01/01/2022
Peer-reviewed
Oui
Volume
8
Numéro
1
Pages
20210080
Langue
anglais
Notes
Publication types: Case Reports
Publication Status: epublish
Publication Status: epublish
Résumé
Bleeding risk after percutaneous portal vein access procedures is not negligible. Various agents, coils and plug, have been used to minimize this risk, each with their own advantages and disadvantages. This study reports the results of coagulation using thermal-ablation (radiofrequency or microwave ablation) as an alternative to trans-hepatic puncture tract closure.
Ten patients who benefited from portal vein recanalization or portal hypertension-relative bleeding complication embolization using percutaneous portal vein access and who underwent thermal-ablation of the puncture tract between December 30, 2019 and July 16, 2020 were included. Early efficiency and safety were evaluated using imaging (ultrasound and/or CT scan) and laboratory data (hemoglobin, hepatic function) at 24 h. Follow-up was performed until August 2020.
No bleeding from the puncture tract and no embolization-related complications were observed in all 10 patients at 24 h or during follow-up with median of 3 months (range 1-8 months), even in case of ascites or therapeutic coagulation.
Thermal-ablation seems to be a safe, effective and rapid technique to avoid bleeding after percutaneous transhepatic direct portal vein access.
Thermal-ablation could be an alternative for transhepatic puncture tract closure especially for patients with high bleeding risk.
Ten patients who benefited from portal vein recanalization or portal hypertension-relative bleeding complication embolization using percutaneous portal vein access and who underwent thermal-ablation of the puncture tract between December 30, 2019 and July 16, 2020 were included. Early efficiency and safety were evaluated using imaging (ultrasound and/or CT scan) and laboratory data (hemoglobin, hepatic function) at 24 h. Follow-up was performed until August 2020.
No bleeding from the puncture tract and no embolization-related complications were observed in all 10 patients at 24 h or during follow-up with median of 3 months (range 1-8 months), even in case of ascites or therapeutic coagulation.
Thermal-ablation seems to be a safe, effective and rapid technique to avoid bleeding after percutaneous transhepatic direct portal vein access.
Thermal-ablation could be an alternative for transhepatic puncture tract closure especially for patients with high bleeding risk.
Mots-clé
General Medicine
Pubmed
Web of science
Open Access
Oui
Création de la notice
04/02/2022 17:41
Dernière modification de la notice
23/11/2022 7:13